Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity
Abstract Representative models are needed to screen new therapies for patients with cancer. Cancer organoids are a leap forward as a culture model that faithfully represents the disease. Mouse-derived cancer organoids (MDCOs) are becoming increasingly popular, however there has yet to be a standardi...
Main Authors: | Rebecca A. DeStefanis, Jeremy D. Kratz, Autumn M. Olson, Aishwarya Sunil, Alyssa K. DeZeeuw, Amani A. Gillette, Gioia C. Sha, Katherine A. Johnson, Cheri A. Pasch, Linda Clipson, Melissa C. Skala, Dustin A. Deming |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-08937-z |
Similar Items
-
Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids
by: Amani A. Gillette, et al.
Published: (2021-04-01) -
Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
by: Joe T. Sharick, et al.
Published: (2020-05-01) -
Ionospheric control of the magnetosphere: conductance
by: A. J. Ridley, et al.
Published: (2004-01-01) -
The shape of the disk: Clues from the kinematics of disk stars
by: Weinberg, MD, et al.
Published: (1996) -
mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers.
by: Dustin A Deming, et al.
Published: (2013-01-01)